Clinical Trials for Gynecologic Cancers

2 Open Trials

Trial Type &
Disease
Protocol No. &
Open Date
Summary
Treatment
Breast;
Colon;
Lung;
Ovarian;
Pancreatic;
Prostate;
Rectal
VICCPHI1394
04/17/2014
A Phase I/II Study of IMMU-132 (hRS7-SN38 Antibody Drug Conjugate) in Patients with Epithelial Cancer
Treatment
Adrenocortical;
Bladder;
Breast;
Cervical;
Colon;
Dermatologic;
Esophageal;
GIST;
Gastric/Gastroesophageal;
Gynecologic;
Head/Neck;
Kidney (Renal Cell);
Liver;
Lung;
Multiple Myeloma;
Neuroendocrine;
Ovarian;
Pancreatic;
Prostate;
Rectal;
Sarcoma;
Small Cell;
Uterine
VICCMD1188
06/08/2012
An Open-Label, Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers

You do not have JavaScript enabled. This site works better with JavaScript turned on.